MAGE-A3 With Cell-Penetrating Domain as an Efficient Therapeutic Cancer Vaccine

JAMA Surgery - United States
doi 10.1001/jamasurg.2013.4113
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

American Medical Association (AMA)

Related search

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

Journal of Cancer
Oncology
2011English

The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Booster Vaccination of Cancer Patients With MAGE-A3 Protein Reveals Long-Term Immunological Memory or Tolerance Depending on Priming

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Self Assembled Cationic Cell Penetrating Peptide Nanoparticles as Efficient Cargoes for Antimicrobial Agents

BMC Infectious Diseases
Infectious Diseases
2014English

Cell-Penetrating Peptides in Vaccine Delivery: Facts, Challenges and Perspectives

Therapeutic Delivery
Pharmaceutical Science
2019English

T Cell Immunoglobulin Domain and Mucin Domain-3 as an Emerging Target for Immunotherapy in Cancer Management

ImmunoTargets and Therapy
AllergyImmunology
2013English

Increased Efficacy of a Dendritic Cell–based Therapeutic Cancer Vaccine With Adenosine Receptor Antagonist and CD73 Inhibitor

Tumor Biology
MedicineCancer Research
2017English

Mage-B Vaccine Delivered by Recombinant Listeria Monocytogenes Is Highly Effective Against Breast Cancer Metastases

British Journal of Cancer
Cancer ResearchOncology
2008English

Small Efficient Cell-Penetrating Peptides Derived From Scorpion Toxin Maurocalcine

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy